Australian panel consults on increasing transparency at TGA
This article was originally published in RAJ Devices
Executive Summary
The committee that is reviewing the way in which Australia's Therapeutic Goods Administration communicates its regulatory processes and decisions to stakeholders is inviting feedback on how information about the agency's functioning can be better conveyed1.